These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9201666)

  • 21. Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations.
    Press NA; Yasui Y; Reynolds S; Durfy SJ; Burke W
    Am J Med Genet; 2001 Mar; 99(2):99-110. PubMed ID: 11241466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
    Cappelli M; Surh L; Humphreys L; Verma S; Logan D; Hunter A; Allanson J
    Clin Genet; 1999 Jun; 55(6):419-30. PubMed ID: 10450858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing participation in BRCA1/2-positive families: initiator role of index cases.
    Blandy C; Chabal F; Stoppa-Lyonnet D; Julian-Reynier C
    Genet Test; 2003; 7(3):225-33. PubMed ID: 14658447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
    Nippert I; Schlegelberger B;
    Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility.
    Benkendorf JL; Reutenauer JE; Hughes CA; Eads N; Willison J; Powers M; Lerman C
    Am J Med Genet; 1997 Dec; 73(3):296-303. PubMed ID: 9415688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer genetic testing: more than a medical management tool.
    Schroeder D; Conroy SA
    Clin J Oncol Nurs; 2015 Oct; 19(5):603-7. PubMed ID: 26414578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing for colorectal carcinoma susceptibility: focus group responses of individuals with colorectal carcinoma and first-degree relatives.
    Kinney AY; DeVellis BM; Skrzynia C; Millikan R
    Cancer; 2001 Jan; 91(1):57-65. PubMed ID: 11148560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women?
    Geller G; Bernhardt BA; Doksum T; Helzlsouer KJ; Wilcox P; Holtzman NA
    J Clin Oncol; 1998 Aug; 16(8):2868-76. PubMed ID: 9704741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
    Beran TM; Stanton AL; Kwan L; Seldon J; Bower JE; Vodermaier A; Ganz PA
    Ann Behav Med; 2008 Oct; 36(2):107-16. PubMed ID: 18787910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.
    Augestad MT; Høberg-Vetti H; Bjorvatn C; Sekse RJ
    J Genet Couns; 2017 Feb; 26(1):182-189. PubMed ID: 27465808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Information-seeking behaviour and psycho-social interactions during the genetic testing process.
    Cypowyj C; Eisinger F; Morin M; Mogoutov A; Sobol H; Julian-Reynier C
    Community Genet; 2003; 6(4):224-34. PubMed ID: 15331868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women's decisions regarding management of breast cancer risk.
    MacDonald DJ
    Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decision making and decision support for hereditary breast-ovarian cancer susceptibility.
    Schwartz MD; Peshkin BN; Tercyak KP; Taylor KL; Valdimarsdottir H
    Health Psychol; 2005 Jul; 24(4S):S78-84. PubMed ID: 16045423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing.
    d'Agincourt-Canning L
    Clin Genet; 2006 Dec; 70(6):462-72. PubMed ID: 17100990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.